The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The changes of HER3 expression in head and neck cancer patients treated with induction chemotherapy.
 
Joori Kim
No Relationships to Disclose
 
Jeong-Oh Kim
No Relationships to Disclose
 
Youn Soo Lee
No Relationships to Disclose
 
Jung-Young Shin
No Relationships to Disclose
 
Min Young Kim
No Relationships to Disclose
 
Mi-Ran Lee
No Relationships to Disclose
 
Seoree Kim
No Relationships to Disclose
 
Saori Fujita-Sato
Employment - Daiichi Sankyo Pharmaceutical
Stock and Other Ownership Interests - Daiichi Sankyo Pharmaceutical
Speakers' Bureau - Bristol-Myers Squibb (I)
Research Funding - Toppan Printing Co. (I)
 
Maki Kobayashi
Employment - Daiichi Sankyo RD Novare
 
Tomoya Kakegawa
No Relationships to Disclose
 
Jin Hyoung Kang
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; Ono Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Genexine; MSD Oncology; Ono Pharmaceutical; Yuhan
Speakers' Bureau - Boehringer Ingelheim; Pfizer; Roche
Research Funding - AstraZeneca; Daiichi Sankyo/UCB Japan; Ono Pharmaceutical; Yuhan